Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lercanidipine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lercanidipine 10mg tablets
0206020L0AAAAAA
|
Lercanidipine hydrochloride | Lercanidipine hydrochloride | Cardiovascular System | 379,850 |
|
Lercanidipine 20mg tablets
0206020L0AAABAB
|
Lercanidipine hydrochloride | Lercanidipine hydrochloride | Cardiovascular System | 365,141 |
|
Zanidip 10mg tablets
0206020L0BBAAAA
|
Zanidip | Lercanidipine hydrochloride | Cardiovascular System | 1,562 |
|
Zanidip 20mg tablets
0206020L0BBABAB
|
Zanidip | Lercanidipine hydrochloride | Cardiovascular System | 804 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.